Akso Health Group (FRA:8HX)

Akso Health Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	995	1,694	393	157	7	35
Market Cap Growth	35.88%	330.64%	150.09%	2005.36%	-78.52%	35.68%
Enterprise Value	997	1,686	315	158	7	32
Last Close Price	1.01	1.98	1.05	1.05	0.25	1.53

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PS Ratio	82.90	141.22	28.77	70.29	0.62	6.44
PB Ratio	6.34	10.80	2.13	1.23	0.92	3.15
P/TBV Ratio	6.34	10.80	2.36	1.23	0.93	3.15
P/FCF Ratio	-	-	415.76	125.59	-	-
P/OCF Ratio	-	-	361.20	125.59	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	80.68	140.56	23.05	70.65	0.59	5.86
EV/FCF Ratio	-	-	333.10	126.24	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.01	0.01	0.01	0.01	1.10	3.03
Debt / FCF Ratio	-	-	2.04	1.48	-	-
Net Debt / Equity Ratio	0.01	0.01	-0.87	-0.60	0.20	1.53
Net Debt / EBITDA Ratio	-1.35	-1.35	98.21	-	-0.12	-7.70
Net Debt / FCF Ratio	-0.17	-0.17	-170.28	-61.55	-0.54	-2.17
Asset Turnover	0.07	0.07	0.08	0.03	0.32	0.13
Inventory Turnover	70.92	70.92	78.96	2.44	2.51	-
Quick Ratio	0.17	0.17	12.83	23.70	1.34	0.37
Current Ratio	21.77	21.77	14.20	39.52	1.76	1.24
Return on Equity (ROE)	-9.85%	-9.85%	-80.26%	-12.38%	-123.87%	-27.75%
Return on Assets (ROA)	-1.24%	-1.24%	-1.37%	-6.64%	-21.42%	-3.25%
Return on Invested Capital (ROIC)	-2.18%	-3.84%	-9.78%	-26.24%	-68.50%	-10.64%
Return on Capital Employed (ROCE)	-2.20%	-2.20%	-2.00%	-6.20%	-161.40%	-20.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-2.65%	-0.96%	-31.75%	-5.57%	-16.75%	-43.61%
FCF Yield	-1.12%	-0.66%	0.24%	0.80%	-40.08%	-22.33%
Buyback Yield / Dilution	-153.50%	-153.50%	-504.37%	-106.30%	-15.07%	-22.06%
Total Shareholder Return	-153.50%	-153.50%	-504.37%	-106.30%	-15.07%	-22.06%

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error